Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

Diabetes

Volumn 52, Issue 8, 2003, Pages 2110-2120

  Babaei Jadidi, Roya ^b   Karachalias, Nikolaos ^b   Ahmed, Naila ^b   Battah, Sinan ^b   Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENFOTIAMINE; THIAMINE; TRANSKETOLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MEGADOSE; GLOMERULUS; HYPERGLYCEMIA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICROALBUMINURIA; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RAT;

ALBUMINURIA; ANIMALS; CHELATING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PENTOSE PHOSPHATE PATHWAY; RATS; RATS, SPRAGUE-DAWLEY; THIAMINE; TRANSKETOLASE;

EID: 0042266256     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.8.2110     Document Type: Article

References (42)

1. Parving H-H, Harrington JT, Lewis J, Boner G, Lewis EJ, Viberti G, Gilbert R, Raz I, Cooper M, Rossing K: Diabetic nephropathy: prevention and treatment. Kidney Internat 60:2041-2055, 2001
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 327:977-986, 1993
3. Stratton IM, Adler AI, Neil, HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemic with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2002
4. Gilbert RE, Tsalamandris C, Bach LA, Panagiotopoulos S, O'Brien RC, Allen TJ, Goodall I, Young V, Seeman E, Murray, RML, Cooper ME, Jerums G: Long-term glycaemic control and the rate of progression of early diabetic kidney disease. Kidney Int 44:855-859, 1993
5. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, Sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 281:2005-2012, 1999
6. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
7. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
8. +. Kidney Int 41:778-788, 1992
9. Ayo SH, Radnik JA, Garoni DA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell culture. Am J Physiol 261:F571-F577, 1991
10. Nishikawa T, Edelstein D, Liang Du X, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beede D, Oates PJ, Hammes, H-P, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemia damage. Nature 404:787-790, 2000
11. Du, X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
12. Thornalley PJ, Jahan I, Ng R: Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. Jpn J Biochem 129:543-549, 2001
13. LaSelva M, Beltrano E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M: Thiamine corrects delayed replication and decreases production of lactate and advanced glycation endproducts in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39:1263-1268, 1997
14. Bergfeld R, Matsumara T, Du X, Brownlee M: Benfotiamin prevents the consequences of hyperglycemia induced mitochondrial overproduction of reactive oxygen species and experimental diabetic retinopathy (Abstract). Diabetologia 44 (Suppl. 1):A39, 2001
15. Subcommittee on Laboratory Animal Nutrition: Nutrient requirement of the laboratory rat. In Nutrient Requirement of Laboratory Animals. Washington DC, National Academy Press, 1995, p. 11-79
16. Brady JA, Rock CL, Horneffer MR: Thiamin status, diuretic medications, and the management of congestive heart failiure. J Am Diet Assoc 95:541-544, 1995
17. Spiro RG: Studies on the renal glomerular basement membrane. J Biol Chem 242:1915-1922, 1967
18. Sander S, Hahn A, Stein J, Rehner G: Comparative studies on the high performance liquid chromatographic determination of thiamine and its phosphate esters with chloroethylamine as an internal standard using precolumn and postcolumn derivatization procedures. J Chromatogr 558:115-124, 1991
19. Chamberlain BR, Buttery JE, Pannall PR: A stable reagent mixture for the whole blood transketolase assay. Ann Clin Biochem 33:352-354, 1996
20. Buchholz A, Takors R, Wandrey C: Quantitation of intracellular metabolites in Escherichia coli K12 using liquid chromatographic-electrospray ionization tandem mass spectrometric techniques. Anal Biochem 295:129-137, 2001
21. Osicka TM, Yu Y, Lee V, Panagiotopoulos S, Kemp BE, Jerums G: Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin Sci 100:149-257, 2001
22. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
23. Thornalley PJ, Langborg A, Minhas HS: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109-116, 1999
24. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77, 1959
25. Meldal M, Kindtler W: Synthesis of a proposed antigenic hexapeptide from Escherichia coli k88 protein fimbriae. Acta Chem Scand Ser B 40:235-241, 1986
26. Finot PA, Mauron J: Le blocage de la lysine par la reaction de Maillard. I. Synthese de N-(desoxy-1-D-fructosyl-1)- et N-(desoxy-1-D-lactulosyl-1)-L-lysine. Helv Chim Acta 52:1488-1495, 1969
27. ε-(1-carboxyethyl)lysine-modified albumin. Biochem J 364:1-14, 2002
28. Soulis-Liparota T, Cooper M, Papazoglou DX, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial cell expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
29. McLellan AC, Thornalley PJ, Benn J, Sonksen PH: The glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci 87:21-29, 1994
30. Lal S, Kappler F, Walker M, Orchard TJ, Beisswenger PJ, Szwergold BS, Brown TR: Quantitation of 3-deoxyglucosone levels in human plasma. Arch Biochem Biophys 342:254-260, 1997
31. Shinohara M, Thornalley PJ, Giardino I, Beisswenger PJ, Thorpe SR, Onorato J, Brownlee M: Overexpression of glyoxalase I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycaemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142-1147, 1998
32. Thornalley PJ: Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 254:751-755, 1988
33. Gastaldi G, Coya E, Verri A, Laforenza U, Faelli A, Rindi G: Transport of thiamin in rat renal brush border membrane vesicles. Kidney Int 57:2043-2054, 2002
34. Pekovich SR, Martin PR, Singleton CK: Thiamine deficiency decreases steady-state transketolase and pyruvate dehydrogenase but not α-ketoglutarate dehydrogenase mRNA levels in three human cell types. J Nutr 128:683-687, 1998
35. Hammes, H-P, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M: Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9:294-299, 2003
36. Saito N, Kimura M, Kuchiba A, Itokawa Y: Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol 33:421-430, 1987
37. Havivi E, Bar On H, Reshef A, Raz I: Vitamins and trace metals status in non insulin dependent diabetes mellitus. Int J Vit Nutr Res 61:328-333, 1991
38. Koya D, Jirousek MR, Lin, Y-W, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
39. Thornalley PJ: Clinical significance of glycation. Clin Lab 45:263-273, 1999
40. Abordo EA, Minhas HS, Thornalley PJ: Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem Pharmacol 58:641-648, 1999
41. Schmidt, A-M, Yan, S-D, Yan SF, Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949-955, 2001
42. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanebe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H: Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108:261-268, 2001